Karl-Ludwig Kley
| Karl-Ludwig Kley | |
|---|---|
 | |
| Born |
11 June 1951 Munich, Germany |
| Nationality | German |
| Occupation | CEO and chairman of Merck |
| Successor | Stefan Oschmann |
Karl-Ludwig Kley (born 11 June 1951 in Munich) is a German business executive, and the chief executive officer (CEO) and chairman of the executive board of the German multinational chemical, pharmaceutical and life sciences company Merck.[1]
Kley worked for Bayer from 1982 to 1998, most recently as head of corporate finance and investor relations. He was chief financial officer and a member of the executive board of Lufthansa 1998–2006. In 2006 he joined Merck as a member of the executive board, and he became CEO of Merck in April 2007.[2][3] In October 2015, it was announced that Kley would retire in April 2016, and be succeeded by Stefan Oschmann.[3]
Kley studied law at LMU 1974–1979 and completed his practical training as a lawyer in Hamburg and Johannesburg from 1979 to 1982. He earned a doctorate in law at LMU in 1986.
References
- ↑ "Karl-Ludwig Kley - Chairman of the Executive Board & CEO of Merck". Merck. Retrieved 14 October 2015.
- ↑ Merck promotes Oschmann as CEO to replace Kley, The Financial Times, 13 October 2015
- 1 2 Divac, Natascha (13 October 2015). "Germany's Merck Names New CEO". WSJ. Retrieved 14 October 2015.
| Business positions | ||
|---|---|---|
| Preceded by Michael Römer |
CEO of Merck 2007–2016 |
Succeeded by Stefan Oschmann |